1. 陈建仁 中国 台湾中央研究院 2017美国科学院院士 Tenofovir use is associated with a decreased risk of hepatocellular carcinoma among men with HIV irr..
2. del Rio, Carlos 美国 Emory University 2013美国医学院院士 Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults 2022 Recommendations of..
3. Vermund, Sten H. 美国 Yale School of Public Health 2012美国医学院院士 Treatment outcomes of HIV patients with hepatitis B and C virus co-infections in Southwest China: an..
4. Ovbiagele, Bruce 美国 San Francisco Veterans Affairs Health Care System 2021美国医学院院士 Prevalence and incidence of pre-diabetes and diabetes mellitus among people living with HIV in Ghana..
5. Nkengasong, John N. 美国 U.S. Department of State 2022美国医学院院士 Access to HIV Viral Load Testing and Antiretroviral Therapy Switch Practices: A Multicountry Prospec..
6. Kanki, Phyllis J. 美国 Harvard School of Public Health 2008美国医学院院士 The impact of HIV-1 subtypes on virologic and immunologic treatment outcomes at the Lagos University..
7. Quinn, Thomas C. 美国 National Institute of Allergy and Infectious Diseases 2004美国医学院院士 Adaptive Viral Load Monitoring Frequency to Facilitate Differentiated Care: A Modeling Study From Ra..
8. Serwadda, David 乌干达 Makerere University 2011美国医学院院士 Adaptive Viral Load Monitoring Frequency to Facilitate Differentiated Care: A Modeling Study From Ra..
9. Swaminathan, Soumya 印度 M S Swaminathan Research Foundation 2017美国医学院院士 Clinical Benefits and Cost-Effectiveness of Laboratory Monitoring Strategies to Guide Antiretroviral..
10. Walensky, Rochelle P. 美国 Centers for Disease Control and Prevention 2021美国医学院院士 Clinical Benefits and Cost-Effectiveness of Laboratory Monitoring Strategies to Guide Antiretroviral..
11. El-Sadr, Wafaa M. 美国 Columbia University, Mailman School of Public Health 2009美国医学院院士 Selecting a viral load threshold for routine monitoring in resource-limited settings: optimizing ind..
12. Wafaie W,Fawzi 美国 Harvard University 2022美国医学院院士 Switching to second-line ART in relation to mortality in a large Tanzanian HIV cohort
13. Haynes, Barton F. 美国 Duke University Medical Center 1997美国医学院院士 Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediat..
14. Shaw, George M. 美国 University of Pennsylvania School of Medicine 2013美国医学院院士 Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediat..
15. Vermund, Sten H. 美国 Yale School of Public Health 2012美国医学院院士 Governmental Support of Research
16. del Rio, Carlos 美国 Emory University 2013美国医学院院士 CD4 Counts at Entry to HIV Care in Mexico for Patients under the "Universal Antiretroviral Treatment..
17. Hernandez-Avila, Mauricio 墨西哥 National Institute of Public Health, Mexico 2013美国医学院院士 CD4 Counts at Entry to HIV Care in Mexico for Patients under the "Universal Antiretroviral Treatment..
18. Pape, Jean W. 美国 Weill Medical College of Cornell University 2003美国医学院院士 Clinical and Virologic Outcomes After Changes in First Antiretroviral Regimen at 7 Sites in the Cari..
19. Quinn, Thomas C. 美国 National Institute of Allergy and Infectious Diseases 2004美国医学院院士 Durable Suppression of HIV-1 after Virologic Monitoring-Based Antiretroviral Adherence Counseling in..
20. Serwadda, David 乌干达 Makerere University 2011美国医学院院士 Durable Suppression of HIV-1 after Virologic Monitoring-Based Antiretroviral Adherence Counseling in..